Tübingen, Germany (ots/PRNewswire) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic ...
Akquisition genehmigt: Türkischer Paketdienstleiser MNG Kargo jetzt Teil von DHL Group - Mit Erhalt der behördlichen Genehmigung vollzieht DHL Group die Übernahme von MNG Kargo zum 5. Oktober - Die Integration wird unter der Führung von DHL ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE First empirical study on impact of targeted advertising ban Spectrum of apps shrinks after ban on personalized ads • Data collection in free apps to be regulated• Ban at Google Play Store led to significantly fewer apps for children • Researchers recommend increasing users' willingness to pay for apps A ban on using apps to collect data in order to personalize advertising ...
Schwarz Corporate Affairs GmbH & Co. KG
dpa Deutsche Presse-Agentur GmbH
Berlin (ots) - Germany is offering support to property owners to install chargers for electric vehicles – applications exhausted the EUR 300 million allocated for 2023 in a single day. The new assistance program is administered by Germany’s development bank, the KfW, and is capped, for the moment, at EUR 500 million. The KfW says that after 33,000 were applications filed within 24 hours, no more requests will be ...
Duesseldorf (ots) - - Gerresheimer presents an extensive portfolio of containment solutions, drug delivery systems and digital therapy support - High-quality ready-to-fill solutions for biopharmaceuticals, cell and gene therapy - EcoDesign and environmentally friendly packaging options ensure greater sustainability Gerresheimer, an innovative system and solution ...
Takeda Pharma Vertrieb GmbH & Co. KG
Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...
